Different bile concentration of micafungin and itraconazole in a patient with candidal cholecystitis

J Infect. 2009 Apr;58(4):315-6. doi: 10.1016/j.jinf.2009.02.004. Epub 2009 Mar 6.

Authors

Takaya Maruyama, Yoshiyuki Takei, Esteban C Gabazza, John Morser, Osamu Taguchi

PMID: 19269034
DOI: 10.1016/j.jinf.2009.02.004

No abstract available

Publication types

Letter

MeSH terms

Aged, 80 and over
Antifungal Agents / analysis
Antifungal Agents / therapeutic use
Bile / chemistry*
Candidiasis / drug therapy*
Candidiasis / etiology
Cholecystitis / drug therapy*
Cholecystitis / etiology
Echinocandins / analysis*
Echinocandins / therapeutic use
Esophageal Neoplasms / complications
Esophageal Neoplasms / drug therapy
Esophageal Neoplasms / therapy
Humans
Itraconazole / analysis*
Itraconazole / therapeutic use
Lipopeptides / analysis*
Lipopeptides / therapeutic use
Male
Micafungin

Substances

Antifungal Agents
Echinocandins
Lipopeptides
Itraconazole
Micafungin